Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus.
Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention.
COVID-19 is not a seasonal illness, with cases all year round. During the winter it can circulate at the same time as the seasonal respiratory infections such as RSV and flu. The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice for the autumn 2025 COVID-19 vaccination programme, which has been accepted by Ministers. The focus of the programme is shifting towards targeted vaccination of those at highest risk of serious disease.
For autumn 2025, COVID-19 vaccination will be offered to:
· adults aged 75 years and over
· residents in care homes for older adults
· individuals who are immunosuppressed, aged 6 months and over
This represents a change from the autumn 2024 programme, which also included adults aged 65 to 74, all those aged 6 months and over in a clinical risk group and pregnant women.
The eligibility is the same across the four nations of the UK (England, Scotland, Wales and Northern Ireland).
The vaccine should usually be offered no earlier than around 6 months after the last vaccine dose. Those who are eligible can get protection from an autumn COVID-19 vaccination even if they have not taken up a COVID-19 vaccine offer in the past.
We understand that determining having a weakened immune system (immunosuppression) may be less straight forward than the other criteria. Some of the groups eligible include:
• Organ, bone marrow or stem cell transplant patients
• Those being treated with systemic steroids for more than a month
• Those living with HIV
• Those receiving immunosuppressive or immunomodulating biological therapy, including children who are about to receive therapy
• Those undergoing chemotherapy or radiotherapy
• Those requiring long-term treatment for immunosuppression
• Those with a history of haematological malignancy including chronic leukaemia, lymphomas, and leukaemia
• Those with genetic disorders affecting the immune system
While this list summarises some major groups, it does not cover everything. Please check online at nhs.uk/get-vaccine to see who is eligible.
FAQs
Who is eligible for COVID-19 vaccination? The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice for the autumn 2025 COVID-19 vaccination programme, which has been accepted by ministers. The focus of the programme is shifting towards targeted vaccination of those at highest risk of serious disease.
For autumn 2025, COVID-19 vaccination will be offered to:
• adults aged 75 years and over
• residents in care homes for older adults
• individuals who are immunosuppressed aged 6 months and over
This represents a change from the autumn 2024 programme, which also included adults aged 65 to 74 and all those aged 6 months and over in a clinical risk group.
The eligibility is the same across the 4 nations of the UK (England, Scotland, Wales and Northern Ireland).
The vaccine should usually be offered no earlier than around 6 months after the last vaccine dose.
I was eligible for the COVID-19 vaccine last winter, why am I no longer eligible this winter?
Thanks to the success of our vaccine programme, we have built a strong, broad immune defences against COVID-19 throughout the population.
Joint Committee on Vaccination and Immunisation (JCVI) advice has continued to adapt as COVID-19 has changed from a pandemic threat to becoming a common milder infection. The JCVI has updated its advice for the autumn 2025 COVID-19 vaccination programme, which has been accepted by ministers. This represents a change from the autumn 2024 programme, which also included adults aged 65 to 74, all those aged 6 months and over in a clinical risk group, and pregnant women.
The focus of the programme is shifting towards targeted vaccination of those at highest risk of serious disease.
